These benefits, together with a previous report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assist the strategy of targeting ACKR3 as a novel method to modulate the opioid program, which could open up new therapeutic avenues for opioid-related Ailments. Title your selection: Title should https://ashleyn848zdv3.blogtov.com/profile